Cite
Contribution of medications and risk factors to QTc interval lengthening in the atherosclerosis risk in communities (ARIC) study.
MLA
Alburikan, Khalid A., et al. “Contribution of Medications and Risk Factors to QTc Interval Lengthening in the Atherosclerosis Risk in Communities (ARIC) Study.” Journal of Evaluation in Clinical Practice, vol. 23, no. 6, Dec. 2017, pp. 1274–80. EBSCOhost, https://doi.org/10.1111/jep.12776.
APA
Alburikan, K. A., Aldemerdash, A., Savitz, S. T., Tisdale, J. E., Whitsel, E. A., Soliman, E. Z., Thudium, E. M., Sueta, C. A., Kucharska-Newton, A. M., Stearns, S. C., & Rodgers, J. E. (2017). Contribution of medications and risk factors to QTc interval lengthening in the atherosclerosis risk in communities (ARIC) study. Journal of Evaluation in Clinical Practice, 23(6), 1274–1280. https://doi.org/10.1111/jep.12776
Chicago
Alburikan, Khalid A, Ahmed Aldemerdash, Samuel T Savitz, James E Tisdale, Eric A Whitsel, Elsayed Z Soliman, Emily M Thudium, et al. 2017. “Contribution of Medications and Risk Factors to QTc Interval Lengthening in the Atherosclerosis Risk in Communities (ARIC) Study.” Journal of Evaluation in Clinical Practice 23 (6): 1274–80. doi:10.1111/jep.12776.